TSHA — Taysha Gene Therapies Inc.

Ownership history in Alphabet Inc.  ·  13 quarters on record

This page tracks every 13F SEC filing in which Alphabet Inc. reported a position in Taysha Gene Therapies Inc. (TSHA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.13% (2023 Q3)
Avg. % of fund
0.07%
First filed
2022 Q3
Last filed
2025 Q3
Quarters held
13
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 640,882 — 0% 0.09% $2.1M $3.27
2025 Q2 UNCHANGED 640,882 — 0% 0.07% $1.5M $2.31
2025 Q1 UNCHANGED 640,882 — 0% 0.06% $891K $1.39
2024 Q4 UNCHANGED 640,882 — 0% 0.06% $1.1M $1.73
9 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    TSHA price (monthly, adj. close)

Other funds also holding TSHA

As of 2025 Q4 — sorted by position size

B Group, Inc. 7.31% Octagon Capital Advisors LP 3Y 5.92% GordonMD Global Investments LP 5.25% SUPERSTRING CAPITAL MANAGEMENT LP 2.89% Ally Bridge Group (NY) LLC 3Y 2.86% Ally Bridge Group (NY) LLC 3Y 2.62% Vestal Point Capital, LP 2.57% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 1.7% Siren, L.L.C. 1.66% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 1.33%
← Back to Alphabet Inc. Holdings